Jessica Chutter was appointed Director of Tectonic Therapeutic, Inc. As of November 6, 2026, Tectonic Therapeutic, Inc. has reported one leadership change filing to the SEC under Item 5.02 of Form 8-K, on April 23, 2026, naming 1 appointment (Form 8-K, April 23, 2026).
30 companies changed executives this week.
Companies that just changed executives, and the new executive. Before you unlock: the company, the change and what is inside. After: the executive named with their role, how to reach the company, and a person's email only when we found one.
| John Hancock Comvest Private Income Fund | named a new Chief Financial Officer | |
| Bain Capital Specialty Finance, Inc. | named a new Director | |
| Azora Therapeutics, Inc. (DE) | named a new Director | |
| LASE Corp. | named a new Director | |
| Century Communities, Inc. | named a new Executive Chairman |
Sell to companies like Tectonic Therapeutic, Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
Tectonic Therapeutic, Inc. reported a change among its directors and officers to the SEC on Form 8-K, Item 5.02, on 2026-04-23. It names 1 person. Every row below is cited to the filing it comes from, and this page adds each new change as Tectonic Therapeutic, Inc. files it.
Also on the record for Tectonic Therapeutic, Inc.
| Date | Record | Figure | Our page | Source |
|---|---|---|---|---|
| October 29, 2026 | Stake report, Schedule 13G/A, by Aberdeen Group plc | 2.48% of the class | 5%+ stakes | Source |
| February 27, 2026 | Stake report, Schedule 13G, by Chen Yu | 6.2% of the class | 5%+ stakes | Source |
| January 29, 2026 | Stake report, Schedule 13G, by Aberdeen Group plc | 6.1% of the class | 5%+ stakes | Source |
| November 14, 2025 | Stake report, Schedule 13G/A, by Deep Track Capital, LP | — | 5%+ stakes | Source |
| November 14, 2025 | Stake report, Schedule 13G/A, by EcoR1 Capital, LLC | — | 5%+ stakes | Source |
| February 14, 2025 | Form D, private offering | $185.03M sold | Form D page | Source |
Selling to them or working with them? See who runs Tectonic Therapeutic, Inc. now and the warning signs.
Free to see. No signup.
Keep reading
More on Tectonic Therapeutic, Inc. and the records around it.
Tectonic Therapeutic, Inc. elsewhere on the record
- 5%+ stake filings Oct 2026
- Who owns it
Companies that share a holder
- Aberdeen Group plc also filed stake reports on 12 other companies: Equillium, Inc. (Nov 2026), IMMUNIC, INC (Nov 2026), CODEXIS, INC. (Oct 2026)
- EcoR1 Capital, LLC also filed stake reports on 20 other companies: Mereo BioPharma Group plc (Aug 2026), Alto Neuroscience, Inc. (Jul 2026), Fulcrum Therapeutics, Inc. (Jun 2026)
- TCG Crossover GP II, LLC also filed stake reports on 21 other companies: ALX Oncology Holdings Inc. (Aug 2026), First Tracks Biotherapeutics, Inc. (Aug 2026), Fulcrum Therapeutics, Inc. (Aug 2026)
Watch Tectonic Therapeutic, Inc.
Get an email when Tectonic Therapeutic, Inc. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
Want the whole picture on Tectonic Therapeutic, Inc.?
Example from a real report (our sample on Target): “Target eliminated approximately 1,800 corporate positions, with around 1,000 employees receiving layoff notices and the remainder accounted for by eliminating open roles.” Source: NBC News
A Full Report on Tectonic Therapeutic, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Tectonic Therapeutic, Inc. covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
7 cited sources found
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
Timeline
| Filed | In / out | Person | Role | Effective | Source |
|---|---|---|---|---|---|
| 2026-04-23 | In | Director | 8-K, 2026-04-23 |
Who leads Tectonic Therapeutic, Inc., as last reported?
For each role that changed in the filings below, the most recent change reported. A role that did not change in these filings is not listed.
- Director: Jessica Chutter, appointed (filed 2026-04-23).
New leaders reset buying decisions — get the Full Report on Tectonic Therapeutic, Inc.: who runs it, how the money works and what to watch, every claim linked to its source.
Get the Full ReportFind people with the same kind of experience as the Director at Tectonic Therapeutic, Inc., with the record behind each one.
Find candidates like Director at Tectonic Therapeutic, Inc.Every change, in the filing's words
Appointed: Jessica Chutter, Director
Ms. Chutter will serve as a Class III director whose term will expire at the Company's 2027 annual stockholder meeting.
- The Board has determined that Ms. Chutter qualifies as an "independent director" as determined in accordance with Rule 5605(a)(2) of the Nasdaq Rules and listing standards.
- The current Compensation Policy provides for: (a) an annual cash retainer of $40,000 per year for service on the Board, (b) an additional $7,500 per year her for service on the Audit Committee and (c) a one-time initial equity award of options to purchase 20,400 shares of the Company's common stock (the "Initial Award").
- The Initial Award will be made pursuant to the Company's 2024 Equity Incentive Plan (the "2024 Plan").
- One-third of the Initial Award will vest on the first anniversary of the date of grant, with the remainder vesting in equal monthly installments thereafter until the third anniversary of the date of grant, subject in each instance to her continued Board service.
- Notwithstanding any vesting schedule, if Ms. Chutter remains in continuous Board service until immediately prior to a "change in control" as defined under the 2024 Plan, all of Ms. Chutter's then-outstanding equity awards granted in connection with the Compensation Policy shall vest and become exercisable in full immediately prior to the closing of such change in control.
Tools for this story
Each opens in a new tab, filled in for Tectonic Therapeutic, Inc.. With no account yet, you sign up free and land on the result.
Where this comes from
A public company must file a current report on Form 8-K with the SEC within four business days when a director leaves or is elected, or when its chief executive, chief financial, chief accounting or chief operating officer, or another named executive, departs or is appointed. That disclosure goes under Item 5.02 of the report.
Every change on this page is taken from one of those filings and quoted in the company's own words, with a link to the filing, so it can be checked at the source. Where a filing names the person, the role and the date a change takes effect, they are shown beside the quote. Where it does not, the quote stands on its own. A filing states what changed; it rarely states why, and neither does this page.